Molecure S.A. (WSE:MOC)
Poland flag Poland · Delayed Price · Currency is PLN
6.17
+0.11 (1.82%)
Aug 14, 2026, 5:00 PM CET

Molecure Earnings Call Transcripts

Fiscal Year 2024

  • Two main clinical programs advanced, with QATD-01 (sarcoidosis) and QATD-02 (solid tumors) progressing in enrollment and dose escalation, respectively. Financials show reduced costs and stable capital, with ongoing efforts to secure partnerships and grants to fund future development.